Wednesday, May 13, 2020

Next Generation Sequencing (NGS) Market to Witness Robust Expansion Throughout the Forecast Period 2019-2030 - 10x Genomics, Beckman Coulter

Next-Generation Sequencing (NGS) is the sequencing of thousands and millions of DNA molecule at the same time. The powerful platform is transforming medical domains, such as genetic diseases, personalized medications, and clinical diagnostics by providing high throughput with abilities of sequencing multiple people simultaneously. Several types of next-generation sequencing machines have been launched in the previous decade, which permit huge parallel sequencing reactions. Every machine efficiently analyzes billions sequencing reactions all together. Even though different machines operate with different technical capabilities, they share few common characteristics.

The common characteristics of NGS machines include:

Preparation of sample:

All the machines require library through either ligation by custom adapter sequences or amplification. The adapter sequences enable library mixture to chip sequencing and offers general priming site for sequencing of primers.

Sequencing:The library fragments are amplified, creating DNA clusters with each cluster playing role in individual sequencing. Every machine has unique cycling process for different applications.

Output:The output obtained from different machines offers raw material (collection of DNA sequences) generated by clusters.

Major Key Players of the Next generation sequencing (NGS) Market are:Agilent Technologies, 10x Genomics, Beckman Coulter (A Subsidiary of Danaher), Becton, Dickinson and Company, Eurofins Scientific, Pacific Biosciences of California, Inc., BGI, Illumina, Inc., F. Hoffmann-La Roche AG, among others.

Read More @ https://www.openpr.com/news/2014850/next-generation-sequencing-ngs-market-to-witness-robust 


No comments:

Post a Comment